Navigation Links
Wes Wheeler Appointed as CEO by Marken's Board of Directors
Date:5/25/2011

LONDON, May 25, 2011 /PRNewswire/ -- The Marken Board of Directors is pleased to announce the appointment of Wesley P. Wheeler, MBA as Chief Executive Officer. Mr. Wheeler succeeds Gerard Barba, who will remain the Chairman of the Marken Board of Directors.

Marken's Board and executive management team have sought to add an executive such as Mr. Wheeler for his in depth of experience in the life science industry as well as a strong background in logistics to further strengthen market leadership and maintain Marken's solid growth path.

Prior to joining Marken, Wes held the title of President and CEO of Patheon Inc., a top contract manufacturing services company. Wes was also a former President of Valeant Pharmaceuticals International, and has previously held senior executive roles of increasing responsibility in manufacturing, marketing and engineering at GlaxoSmithKline, plc. Preceding his 22 year career in pharmaceuticals, Mr. Wheeler had a successful 12 year career at ExxonMobil. He holds a bachelor's degree in Mechanical Engineering and a Masters of Business Administration.

"As the nature of biopharmaceutical R&D changes, well controlled clinical supply chains will be a significant factor in the success of key life science companies and the industries that support them. The Board and I feel that Wes can bring his experience from the drug manufacturing, biotechnology and traditional pharmaceutical industries to augment an already strong management team and continue Marken's growth," said Gerard Barba, Marken's Chairman.

Mr. Khawar Mann, managing partner, APAX LLP., said: "We are delighted that Wes has agreed to join us at Marken. His operations background and successful track record in the pharmaceutical industry will give us the tools we need to continue building Marken's portfolio of services and geographies, and thus realize our greatest potential as a leading logistics services provider."

About Marken

Founded in
'/>"/>

SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dr. David Heimbrook Appointed Chief Executive Officer of SAIC-Frederick, Inc.
2. GRAPHENE-CA appointed an EU Future Emerging Technology flagship pilot
3. David P. Lang Appointed Vice President of CryoLife International, Inc.
4. Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA
5. Torbjorn Bjerke Appointed as new CEO for Karolinska Development
6. Shawn Cross Appointed CEO of Burrill Merchant Banking Group
7. New President and CEO appointed at Ocean Nutrition Canada Limited
8. Professor Sander van Deventer Appointed to Supervisory Board of AMT
9. New Board Director Appointed
10. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
11. Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Calif. , May 5, 2015  23andMe, Inc., ... of the Lupus Research Study in collaboration ... individuals with systemic lupus erythematosus, more commonly known as ... genetics of lupus. The effort is also in collaboration ... Lupus Awareness Month in May. Approximately 1.5 ...
(Date:5/5/2015)... Israel , May 5, 2015  Tikcro ... Company was approved to continue trading on OTCQB  ... OTCQB Marketplace allows for a continuous ... broker-dealers. Investors can have real-time quotes and market ... The OTCQB Marketplace includes U.S. and ...
(Date:5/5/2015)... 5, 2015  A group of biotechnology executives and ... Research Institute, a non-profit organization dedicated to providing education, ... from disorders of consciousness.  ... ... which no voluntary actions can be initiated by the ...
(Date:5/5/2015)... 2015 CytomX, a biotechnology company developing Probody™ ... Sean McCarthy , D. Phil., chief executive officer, ... New York at 1:15 p.m. ... an overview of CytomX,s Probody pipeline, including the company,s ... About CytomX Therapeutics CytomX Therapeutics develops Probody™ ...
Breaking Biology Technology:23andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 3Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 4Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 5
... LAVAL, QC, Oct. 15 /PRNewswire-FirstCall/ - Neptune ... is pleased to,announce the appointment of a ... comprised of 5 renowned scientists. Neptune ... of the new,members of the Advisory Board ...
... Oct. 15 Wyeth,Pharmaceuticals, a division of Wyeth ... presented today at the 63rd Annual Meeting of ... women who received 100 mg/day or,150 mg/day of ... a significant reduction in moderate to severe,vasomotor symptoms ...
... Inc.,(Nasdaq: ORCH ), a leading worldwide provider ... quarter 2007 financial results on,Thursday, November 1, 2007 ... a,conference call and webcast to discuss the results ... will discuss financial results for the third quarter,2007 ...
Cached Biology Technology:Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 2Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 3Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo 2Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo 3Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo 4Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo 5Orchid Cellmark to Announce Third Quarter 2007 Financial Results on November 1, 2007 2
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, the ... users across iOS and Android ... integrating biofeedback into the platform to allow patients to ... For the first time, patients will be able to ... dose impacts important biometrics, such as glucose levels and ...
(Date:3/26/2015)... The Granite Club, Canada,s ... announced it has implemented a state-of-the-art access and security ... and staff, while restricting access to authorized users only. ... IMID Access system because it has the perfect combination ... in addition to unparalleled security," said James DiRenzo ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ... solutions, today announced that its U.are.U ® ... retailer Goorin Bros . to achieve PCI ... solution secures access to the POS terminal, protecting ... risk of data breaches. With ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... of Pennsylvania survey of dog owners who use confrontational ... have found that most of these animals will continue ... The study, published in the current issue of ... non-aversive or neutral training methods such as additional exercise ...
... Singapore Centre for Drug Discovery (LSCDD), Singapore,s National Neuroscience ... (SICS), have teamed up to advance drug discovery using ... one of the institutions of SingHealth, the largest public ... of the US-based biopharmaceutical company, Eli Lilly and Company ...
... microscopic channels called plasmodesmata that are embedded in their ... growing tips, called "meristems," the plasmodesmata are lifelines, allowing ... Developmental and environmental cues trigger changes in the ... of traffic through them. The genes and molecular pathways ...
Cached Biology News:If you're aggressive, your dog will be too, says veterinary study at University of Pennsylvania 2Singapore research organisations team up to advance drug discovery using brain tumor stem cells 2CSHL researchers identify gene that helps plant cells keep communication channels open 2CSHL researchers identify gene that helps plant cells keep communication channels open 3
Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
... of the members of the GPCR family ... splicing--which has important implications for drug research. ... classical expression profiling and at the same ... of the gene that are expressed in ...
... 5.6" TFT color screen, without Camera ... camera with 8.0 mega pixel resolution. It is ... budget. View image from large 5.6" TFT color ... is suitable to capture image for fluorescent gels, ...
... The binding specificity and signaling of ... known to be modified by alternative splicing--which ... GPCR SpliceArrays you can perform a classical ... detect the different alternatively spliced forms of ...
Biology Products: